Hind Rafei, MD¹, Hagop M. Kantarjian, MD², Koji Sasaki, MD³, Nicholas J. Short, MD⁴, Farhad Ravandi, MBBS⁵, Xuelin Huang, PhD^6*, Joseph D. Khoury, MD⁷, Sa A Wang, MD^8*, Jeffrey L. Jorgensen, MD, PhD^8*, Issa F. Khouri, MD⁹, Partow Kebriaei, MD⁹, Nitin Jain, MD¹⁰, Bouthaina S. Dabaja, MD^11*, Yesid Alvarado, MD³, Tapan M. Kadia, MD¹², Shilpa Paul, PharmD^13*, Serena Chew, PharmD^13*, Guillermo Garcia-Manero, MD⁴, Jan A. Burger, MD, PhD⁴, Courtney D. DiNardo, MD, MSc¹⁴, Naval Daver, MD¹⁵, Guillermo Montalban-Bravo, MD^4*, Musa Yilmaz, MD³, Maro Ohanian, DO^4*, Maria Khouri^4*, Philip A. Thompson, MB, MS¹⁶, Jovitta Jacob^4*, Meagan Rostykus, RN^4*, Rebecca Garris, MSc^4*, Marina Konopleva, MD, PhD¹⁷, Susan M. O'Brien, MD¹⁸ and Elias Jabbour, MD⁴

¹MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, Professor and Chairman, Department of Leukemia, Samsung Distinguished University Chair in Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
⁶Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Associate Professor of Medicine Department of Leukemia The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹²Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
¹³Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁴Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
¹⁵Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX
¹⁶The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁷Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX
¹⁸UCI Cancer Center, Orange, CA

Xavier Thomas, MD, PhD¹, Anita W Rijneveld, MD, PhD^2*, Nicola Fracchiolla, MD^3*, Cyril Šálek, MD^4*, Alexandros Spyridonidis, MD, PhD^5*, Sabina Chiaretti, MD, PhD⁶, Naufil Alam, PhD^7*, Isabella Pezzani Grueter, PharmD^8*, Abeera Mohammad, MSc^9*, William Kormany, MD^10*, Georg Kreuzbauer, MD^8* and Alessandro Rambaldi, MD¹¹

¹Department of Hematology, Hospices Civils de Lyon, Lyon-Sud Hospital, Pierre-Bénite, Lyon, France
²Department of Hematology, Erasmus University Medical Center, Rotterdam, Netherlands
³UOC Oncoematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Di, Milan, ITA
⁴Institute of Hematology and Blood Transfusion, Prague, Czech Republic
⁵General University Hospital of Patra, PATRA, Greece
⁶Department of Translational and Precision Medicine, Division of Hematology, Rome, Italy
⁷Center for Observational Research, Amgen Ltd, Uxbridge, United Kingdom
⁸Amgen (Europe) GmbH, Rotkreuz, Switzerland
⁹Global Biostatistical Science, Amgen Ltd, Uxbridge, United Kingdom
¹⁰Global Patient Safety, Amgen Inc, Thousand Oaks, CA
¹¹Department of Oncology-Hematology, University of Milan and Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy

Hind Rafei, MD¹, Hagop M. Kantarjian, MD^2,3, Koji Sasaki, MD⁴, Nicholas J. Short, MD², Farhad Ravandi, MBBS⁵, Xuelin Huang, PhD^6*, Joseph D. Khoury, MD⁷, Sa A Wang, MD^8,9*, Jeffrey L. Jorgensen, MD, PhD^9*, Issa F. Khouri, MD¹⁰, Partow Kebriaei, MD¹⁰, Richard E. Champlin, MD¹⁰, Nitin Jain, MD¹¹, Bouthaina S. Dabaja, MD^12*, Ghayas C. Issa, MD¹³, Naveen Pemmaraju, MD², Tapan M. Kadia, MD¹⁴, Shilpa Paul, PharmD^15*, Nadya Jammal, PharmD^15*, Guillermo Garcia-Manero, MD², William G. Wierda, MD, PhD¹⁶, Courtney D. DiNardo, MD, MSc¹⁷, Naval Daver, MD¹⁸, Guillermo Montalban-Bravo, MD^2*, Rita Khouri^19*, Patrice Nasnas, MD^2*, Philip A. Thompson, MB, MS²⁰, Jovitta Jacob^2*, Meagan Rostykus, RN^2*, Rebecca Garris, MSc^2*, Marina Konopleva, MD, PhD²¹, Susan M. O'Brien, MD²² and Elias Jabbour, MD²

¹MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, Professor and Chairman, Department of Leukemia, Samsung Distinguished University Chair in Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
⁶Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
⁸University of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, TX
⁹Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Associate Professor of Medicine Department of Leukemia The University of Texas MD Anderson Cancer Center, Houston, TX
¹²Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹³Department of Leukemia, Universit Y of Texas At Houston, Houston, TX
¹⁴Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
¹⁵Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁶Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
¹⁷Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
¹⁸Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX
¹⁹University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX
²⁰The University of Texas MD Anderson Cancer Center, Houston, TX
²¹Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX
²²UCI Cancer Center, Orange, CA

Philip C. Amrein, MD¹, Karen K. Ballen, MD², Kristen E. Stevenson, MS^3*, Traci M. Blonquist, MS^4*, Andrew M. Brunner^5*, Gabriela S. Hobbs, MD⁶, Hanno R. Hock, MD, PhD^7*, Steven L. McAfee, MD^8*, Jenna A. Moran, NP^6*, Meghan Bergeron, NP^6*, Julia E. Foster, NP^6*, Christina Bertoli, NP^6*, Kristin McGregor^6*, Molly Macrae^6*, Meghan Burke^6*, Tanya T. Behnan, BS^6*, Tina T. Som, RN^6*, Aura Y. Ramos, RN^6*, Megan K. Vartanian, RN^6*, Jennifer Lombardi Story^6*, Christine Connolly^6*, Timothy A. Graubert, MD⁹, Donna S. Neuberg, ScD³ and Amir T. Fathi¹⁰

¹Leukemia Center/MGH Cancer Center, Massachusetts General Hospital, Belmont, MA
²Division of Hematology/Oncology, University of Virginia Health Center, Charlottesville, VA
³Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁴Data Science, Dana-Farber Cancer Institute, Boston, MA
⁵Center for Leukemia, Massachusetts General Hospital, Boston, MA
⁶Leukemia Center, Massachusetts General Hospital, Boston, MA
⁷Leukemia Center, Massachusetts General Hospital / Harvard Medical School, Boston, MA
⁸Massachusetts General Hospital, Blood and Marrow Transplant Program, Boston, MA
⁹Leukemia Center, Massachussets General Hospital, Charlestown, MA
¹⁰Leukemia Center, Massachusetts General Hospital, Center for Leukemia, Cambridge, MA

Jenna Rossoff, MD¹, Christina Baggott, RN, PhD^2*, Snehit Prabhu, PhD^2*, Holly Pacenta, MD³, Christine L Phillips, MD^4,5, Heather Stefanski, MD, PhD⁶, Julie-An Talano, MD⁷, Amy Moskop, MD⁷, Steven P. Margossian, MD, PhD⁸, Michael R Verneris, MD⁹, Gary Douglas Myers, MD^10*, Nicole Karras, MD^11*, Patrick A. Brown, MD¹², Muna Qayed, MD, MSc¹³, Michelle Hermiston, MD, PhD¹⁴, Prakash Satwani, MD^15*, Christa Krupski, DO, MPH^16*, Amy Keating, MD^17*, Rachel Wilcox^18*, Cara A Rabik, MD, PhD^19,20, Vanessa Fabrizio, MD^21,22, Michael Kunicki^23*, Vasant Chinnabhandar, MD^6*, A. Yasemin Goksenin, MD, PhD, MA, MPH^24*, Kevin J. Curran, MD^22,25, Crystal L. Mackall, MD²⁶, Theodore W. Laetsch, MD²⁷ and Liora M. Schultz, MD²⁸

¹Division of Pediatric Hematology/Oncology/Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
²Stanford University School of Medicine, Stanford, CA
³Cook Children's Medical Center, Fort Worth, TX
⁴Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
⁵University of Cincinnati College of Medicine, Cincinnati, OH
⁶Department of Pediatrics, Division of Pediatric Blood and Marrow Transplantation, University of Minnesota Medical School, Minneapolis, MN
⁷Medical College of Wisconsin, Milwaukee, WI
⁸Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA
⁹University of Colorado, Anschutz Medical Campus, Colorado Children’s Hospital, Aurora, CO
¹⁰Children's Mercy Hospital, Kansas City, MO
¹¹Department of Pediatrics, City of Hope National Medical Center, Duarte, CA
¹²The Johns Hopkins Hospital, Baltimore, MD
¹³Pediatric Blood and Marrow Transplantation Program, Aflac Cancer and Blood Disorders Center, Emory University and Children’s Healthcare of Atlanta, Atlanta, GA
¹⁴University, San Francisco, CA
¹⁵Division of Pediatric Hematology, Oncology, and Stem Cell Transplant, Department of Pediatrics, Columbia University Medical Center, New York, NY
¹⁶Department of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
¹⁷University of Colorado, Anschutz Medical Campus Colorado Children’s Hospital, Aurora, CO
¹⁸Childern's Mercy Hospital, Kansas
¹⁹Pediatric Oncology, Bloomberg Children's Center, Baltimore, MD
²⁰The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
²¹Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
²²Department of Pediatrics, Weill Cornell Medical College, New York, NY
²³Stanford University School of Medicine, Department of Pediatrics, Division of Hematology and Oncology, Palo Alto, CA
²⁴UCSF Benioff Children’s Hospital, San Francisco, CA
²⁵Department of Pediatrics, BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY
²⁶Department of Pediatrics, Division of Hematology and Oncology, Stanford University, Stanford, CA
²⁷Department of Pediatrics and Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX
²⁸Department of Pediatrics, Division of Hematology and Oncology, Stanford University School of Medicine, Palo Alto, CA

Wei Cui^1*, Xinyue Zhang^2*, Haiping Dai^3*, Qingya Cui^1*, Baoquan Song^4*, Depei Wu, MD, PhD⁵, Xiaowen Tang, MD, PhD^1*, Jia Yin^4* and Zheng Li^2*

¹National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
²National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China 215006., Soochow, Jiangsu, China
³Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, China
⁴Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
⁵The First Affiliated Hosp. of Soochow University, Suzhou, Jiangsu, China

Nora Zieger^1,2*, Alyssa Nicholls^1,2*, Jan Wulf^1,2*, Gerulf Hänel^1,2*, Maryam Kazerani Pasikhani^1,2*, Veit Buecklein, MD^1,2*, Bettina Brauchle^1,2*, Anetta Marcinek^1,2*, Daniel Nixdorf^1,2*, Lisa Rohrbacher^1,2*, Michaela Scheurer^1,2*, Roman Kischel, MD^3*, Karsten Spiekermann, MD^2,4,5, Oliver Weigert, MD^2,4, Sebastian Theurich, MD^2*, Michael von Bergwelt, MD, PhD^2* and Marion Subklewe, MD^1,2,5

¹Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany
²Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
³Amgen Research (Munich) GmbH, Munich, Germany
⁴Experimental Leukemia and Lymphoma Research (ELLF), University Hospital, LMU Munich, Munich, Germany
⁵German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany

Hind Rafei, MD¹, Hagop M. Kantarjian, MD², Koji Sasaki, MD³, Nicholas J. Short, MD⁴, Farhad Ravandi, MBBS⁵, Xuelin Huang, PhD^6*, Joseph D. Khoury, MD⁷, Sa A Wang, MD^8*, Jeffrey L. Jorgensen, MD, PhD^8*, C. Cameron Yin, MD, PhD⁸, Issa F. Khouri, MD⁹, Partow Kebriaei, MD⁹, Nitin Jain, MD¹⁰, Koichi Takahashi, MD, PhD¹¹, Bouthaina S. Dabaja, MD^12*, Srdan Verstovsek, MD, PhD⁴, Tapan M. Kadia, MD¹³, Shilpa Paul, PharmD^14*, Caitlin R. Rausch, PharmD^15*, Guillermo Garcia-Manero, MD⁴, William G. Wierda, MD, PhD¹⁶, Courtney D. DiNardo, MD, MSc¹⁷, Naval Daver, MD¹⁸, Guillermo Montalban-Bravo, MD^1*, Musa Yilmaz, MD³, Patrice Nasnas, MD^4*, Rita Khouri^4*, Monica Kwari, BSN⁴, Jovitta Jacob^4*, Meagan Rostykus, RN^4*, Rebecca Garris, MSc^4*, Marina Konopleva, MD, PhD¹⁹, Susan M. O'Brien, MD²⁰ and Elias Jabbour, MD⁴

¹MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, Professor and Chairman, Department of Leukemia, Samsung Distinguished University Chair in Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
⁶Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Associate Professor of Medicine Department of Leukemia The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
¹²Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹³Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
¹⁴Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁵Pharmacy, MD Anderson Cancer Center, Houston, TX
¹⁶Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
¹⁷Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
¹⁸Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX
¹⁹Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX
²⁰UCI Cancer Center, Orange, CA

Iris Appelmann, MD^1*, Azam Salimi^1*, Michael Huber, PhD^2*, Mirle Schemionek, PhD^3*, Margherita Vieri, PhD^4*, Tim H Brümmendorf, MD⁵, John B. Patterson^6* and Behzad Kharabi Masouleh, MD⁷

¹Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany
²Institute of Biochemistry and Molecular Immunology, RWTH Aachen University, Aachen, Germany
³Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, RWTH Aachen University, Aachen, Germany
⁴Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, University Hospital Aachen, Aachen, Germany
⁵Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, RWTH Aachen University, Aachen, Germany
⁶Orinove Inc., Newbury Park, CA
⁷Kite Pharma, Santa Monica

Wenyi Lu, MD^1*, Yunxiong Wei^2*, Yaqing Cao^1*, Xia Xiao, MD^1*, Qing Li^1*, Hairong Lyu^1*, Yili Jiang^1*, Huan Zhang^1*, Jia Wang^1*, Xin Li^1*, Yanyu Jiang^1*, Meng Juanxia^1*, Yuan Ting^1*, Haibo Zhu^1*, Xiaoyuan He^3*, Xin Jin^3*, Rui Sun^1*, Tao Sui^1*, Kaiqi Liu^4* and Mingfeng Zhao, MD, PhD¹

¹Department of Hematology, Tianjin First Central Hospital, Tianjin, China
²Department of Hematology, Tianjin First Center Hospital, Tianjin, China
³School of Medicine，Nankai University，China, Tianjin, China
⁴State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Qiuling Chen, MS^1,2*, Yuelong Jiang, MS^2*, Qinwei Chen, MD, PhD^2*, Long Liu, MD, PhD^2* and Bing Xu, MD, PhD^1,2*

¹Department of Hematology, The School of Clinical Medicine, Fujian Medical University, Fuzhou, China
²Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China